• Home
  • Articles
  • Regions
    • Africa
    • Americas & the Caribbean
    • Asia
    • Australia & Oceania
    • Europe
    • EECA
  • Issues
    • Drug Harm Reduction
    • Drug Policy
    • Drug Trafficking
    • Drugs & Development
    • Drugs & Race
    • Drugs & Gender
    • Personal Stories
  • Drugs
    • Cannabis
    • Opioids
    • Coca & Cocaine
    • Psychedelics
    • Stimulants
    • Other Drugs
  • Resources
  • About Us
    • Work With Us
A bottle of pharmaceutical fentanyl.

How Patients Became Collateral Damage in Mexico’s War on Fentanyl

“Matter of Life or Death”: The Public Health Costs of Disrupting US Aid in Africa

Downtown eastside of Vancouver in British Columbia, an area of the Canadian city highly impacted by decriminalisation.

“Starting to Brew”: How Decriminalisation Impacts People Using Drugs in Canada

Punjab Needs Healing: Drug Policy Struggles in India

European Harm Reduction Is Facing a Funding Crisis

Australian Government Dismisses Decriminalisation Despite Widespread Support

US Study Highlights How Drug Criminalisation Prevents Care

Counting Down: PsychedeliCare Launches Citizen’s Campaign for Psychedelic Therapy

“We Won’t Win” – A Pessimistic Outlook for the Black Future of Rio de Janeiro

A Historic Vote at the CND: Colombia Challenges the Global Drug Control System

Two Months In, A Deeper Look at The Thistle, Glasgow’s Drug Consumption Room

Spain’s Decriminalisation: Decades of Quiet Innovation

1 2 3 4 … 64 Next

Copyright © TalkingDrugs.org. All rights reserved.

  • Privacy Policy
  • Terms & Conditions
  • Cookies
Webpop Design

Attribution-NonCommercial 4.0